v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Net sales $ 3,312,800 $ 2,240,005
Cost of sales 2,458,854 1,843,784
Gross profit 853,946 396,221
Operating expenses    
Research and development 205,333 369,601
General and administrative 4,239,154 3,414,822
Sales and marketing 2,155,867 869,749
(Gain) loss on foreign exchange (2,231) (1,645)
Total operating expenses 6,598,123 4,652,527
Loss from operations (5,744,177) (4,256,306)
Other income (expense)    
Interest expense (92,383) (195,438)
Other 8,038 (8,720)
Total other income (expense) (84,345) (204,158)
Net loss $ (5,828,522) $ (4,460,464)
Loss per share (basic) $ (0.54) $ (1.05)
Loss per share (diluted) $ (0.54) $ (1.05)
Weighted average number of shares (basic) 10,778,204 4,262,474
Weighted average number of shares (diluted) 10,778,204 4,262,474